GRAIL
0
96
+$0.00+0% 00:00 Today
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Earnings
18AugExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-6.43
-5.05
-3.67
-2.29
Expected EPS
-2.651922
Actual EPS
N/A
Financials
-298.5%Profit Margin
Unprofitable103.58MRevenue
-309.18MNet Income
Analyst Ratings
65.00Average Price Target
The highest estimate is 75.00.
From 5 ratings within the last 6 months. This is not an investment recommendation.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy 40%
Hold 60%
Sell 0%
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
Show more...
CEO
Joshua J. Ofman
Employees
910
Country
United States
Listings
0 Comments
Share your thoughts
FAQ
What is GRAIL stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange GRAIL stocks are traded under the ticker GRAL V.
What is GRAIL revenue for the last year?▼
GRAIL revenue for the last year amounts to 103.58M USD.
What is GRAIL net income for the last year?▼
GRAL V net income for the last year is -309.18M USD.
How many employees does GRAIL have?▼
As of August 24, 2026, the company has 910 employees.
In which sector is GRAIL located?▼
GRAIL operates in the Health & Wellness sector.
When did GRAIL complete a stock split?▼
GRAIL has not had any recent stock splits.
Where is GRAIL headquartered?▼
GRAIL is headquartered in MENLO PARK, United States.